UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ADAPT PHARMA LIMITED, and
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owners.
`__________________
`
`Case No. IPR2019-00697
`U.S. Patent No. 9,775,838
`__________________
`
`JOINT AMENDED MANDATORY NOTICES OF
`PATENT OWNERS ADAPT PHARMA LIMITED AND
`OPIANT PHARMACEUTICALS, INC.
`
`
`
`
`
`
`
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ADAPT PHARMA LIMITED, and
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owners.
`__________________
`
`Case No. IPR2019-00697
`U.S. Patent No. 9,775,838
`__________________
`
`JOINT AMENDED MANDATORY NOTICES OF
`PATENT OWNERS ADAPT PHARMA LIMITED AND
`OPIANT PHARMACEUTICALS, INC.
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owners Adapt Pharma Limited
`
`Case No. IPR2019-00697
`U.S. Patent No. 9,775,838
`
`
`
`(“Adapt”) and Opiant Pharmaceuticals, Inc. (“Opiant”) jointly submit the
`
`following amended mandatory notices:
`
`I.
`
`Real Parties in Interest, 37 C.F.R. § 42.8(b)(1)
`Adapt and Opiant are the assignees, and Adapt Pharma Operations Limited,
`
`a wholly owned subsidiary of Adapt, is a limited exclusive licensee, of U.S. Patent
`
`No. 9,561,177 and U.S. Patent No. 9,775,838. Opiant is the assignee, and Adapt
`
`Pharma Operations Limited is a limited exclusive licensee, of U.S. Patent No.
`
`9,211,253; U.S. Patent No. 9,468,747; and U.S. Patent No. 9,629,965.
`
`Adapt is a wholly owned subsidiary of Emergent Acquisitions Limited.
`
`Emergent Acquisitions Limited is a wholly owned subsidiary of Emergent
`
`International Inc., which is a wholly owned subsidiary of Emergent BioSolutions
`
`Inc. Emergent BioSolutions Inc. is a publicly held company, and no publicly held
`
`company owns 10% or more of Emergent BioSolutions Inc.’s stock. Opiant is a
`
`publicly held company, and no publicly held company owns 10% or more of
`
`Opiant’s stock.
`
`II. Related Matters, 37 C.F.R. § 42.8(b)(2)
`Petitioner Nalox-1 Pharmaceuticals, LLC (“Nalox-1”) has filed the
`
`following related petitions for inter partes review:
`
`
`
`2
`
`
`
`Case No. IPR2019-00697
`
`US. Patent No. 9,775,838
`
`., usnm.um
`
`
`
`US. Patent No. 9,211,253; US. Patent No. 9,468,747; US. Patent No.
`
`9,561,177; US. Patent No. 9,629,965; and US. Patent No. 9,775,838 are being
`
`asserted in Adapt Pharma Operations Ltd., et a]. v. Teva Pharmaceuticals USA,
`
`Inc., et al., Case 2: l6-cv-07721-JLL-JAD (D.N.J.) (consolidated), filed October
`
`21, 2016; and Adapt Pharma Operations Ltd, et a]. v. Perrigo UK FINCO Limited
`
`Partnership, Case 2: 18-cv-15287-JLL-JAD (D.N.J.), filed October 25, 2018.
`
`Administrative matters that would be or could be affected by this proceeding
`
`include pending US. patent applications 15/415,221; 15/494,270; and 16/ l 3 1 ,641.
`
`
`
`
`III. Lead & Backup Counsel, 37 C.F.R. § 42.8(b)(3)
`Adapt designates the following attorney as lead counsel:
`
`Case No. IPR2019-00697
`U.S. Patent No. 9,775,838
`
`Jessamyn S. Berniker
`Reg. No. 72,328
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`jberniker@wc.com
`
`Opiant designates the following attorney as first backup counsel:
`
`Robert F. Green
`Reg. No. 27,555
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue, Suite 3900
`Chicago, IL 60611
`rgreen@greengriffith.com
`
`Adapt designates the following attorneys as backup counsel:
`
`David M. Krinsky
`Reg. No. 72,339
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`dkrinsky@wc.com
`
`Anthony H. Sheh
`Reg. No. 70,576
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5436
`F: (202) 434-5029
`asheh@wc.com
`
`4
`
`
`
`
`
`Case No. IPR2019-00697
`U.S. Patent No. 9,775,838
`
`Opiant designates the following attorney as backup counsel:
`
`Jessica Tyrus Mackay
`Reg. No. 64,742
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue, Suite 3900
`Chicago, IL 60611
`jmackay@greengriffith.com
`
`Powers of attorney appointing these attorneys to transact all business in this
`
`proceeding on behalf of Adapt or Opiant, respectively, have been submitted or will
`
`be submitted with this amended mandatory notice information.
`
`IV. Service Information, 37 C.F.R. § 42.8(b)(4)
`Counsel for Adapt and Opiant submit the following service information:
`
`Electronic mail addresses:
`
`Postal mail addresses:
`
`Telephone numbers:
`
`Facsimile number:
`
`
`
`jberniker@wc.com,
`dkrinsky@wc.com,
`asheh@wc.com, tkenner@wc.com,
`rgreen@greengriffith.com,
`jmackay@greengriffith.com
`Jessamyn S. Berniker
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`Jessica Tyrus Mackay
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`
`(202) 434-5000, (313) 883-8000
`
`(202) 434-5029
`
`5
`
`
`
`Counsel for Adapt consent to electronic service by email at
`
`Case No. IPR2019-00697
`U.S. Patent No. 9,775,838
`
`
`
`jberniker@wc.com, dkrinsky@wc.com, asheh@wc.com, and tkenner@wc.com.
`
`Counsel for Opiant consents to electronic service by email at
`
`rgreen@greengriffith.com and jmackay@greengriffith.com.
`
`
`Date: April 12, 2019
`
`
`
`
`
`Respectfully submitted,
`
`
`/Jessamyn S. Berniker/
`Jessamyn S. Berniker (Reg. No. 72,328)
`David M. Krinsky (Reg. No. 72,339)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`jberniker@wc.com
`dkrinsky@wc.com
`asheh@wc.com
`
`Counsel for Patent Owner
`Adapt Pharma Limited
`
`/Jessica Tyrus Mackay/
`Robert F. Green (Reg. No. 27,555)
`Jessica Tyrus Mackay (Reg. No. 64,742)
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`(313) 883-8000
`jmackay@greengriffith.com
`
`Counsel for Patent Owner
`Opiant Pharmaceuticals, Inc.
`
`
`
`6
`
`
`
`Case No. IPR2019-00697
`
`US. Patent No. 9,775,838
`
`W
`
`Pursuant to 37 CPR. § 42.6(e), the undersigned hereby certifies that a true
`
`and correct copy of the foregoing was served on April 12, 2019, by delivering a
`
`copy via electronic mail on the following attorneys of record:
`
`Yelee Y. Kim
`
`Janine A. Carlan
`
`Richard Bennan
`
`Bradford Frese
`
`Christopher Yaen
`ARENT FOX LLP
`
`1717 K Street NW
`
`Washington, DC 20036
`Yelee.Kim@arentfox.com
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`/Jessica Tyrus Mackay/
`Jessica Tyrus Mackay
`Reg. No. 64,742
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
